+33 1 76 70 47 90
/
creativ@creativ-ceutical.com
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
[PMH14] PROMINENT NEGATIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA: FINDINGS FROM THE EUROSC STUDY
Home
Publications
[PMH14] PROMINENT NEGATIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA: FINDINGS FROM THE EUROSC STUDY
Back Home
[PMH14] PROMINENT NEGATIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA: FINDINGS FROM THE EUROSC STUDY
2017 ISPOR 22nd Annual International Conference
Millier, A. | Mejri, A. | Toumi, M. |
Volume: 20, Issue: 5, Pages: A293-A294,
The website uses cookies.
Learn More
Ok
